The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Open accessAbstract
Resources from the National Institutes of Health Chemical Genomics Center include a database and a physical collection of approved drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“For example, using such an approach the antibiotic ceftriaxone was determined to represent a possible treatment for amyotrophic lateral sclerosis (17), and the antihistamine astemizole was identified as a potential antimalarial drug (18).”
BackgroundChong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Feasey, N., Wansbrough-Jones, M., Mabey, D. C. W., & Solomon, A. W. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp046 · Cited by 817
Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., & Austin, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604348103 · Cited by 792
Self-citationSildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
The cost of biopharmaceutical R&D: is biotech different?
DiMasi, J. A., & Grabowski, H. G. (2007) · Managerial and Decision Economics · doi:10.1002/mde.1360 · Cited by 517
Wysowski, D. K., & Swartz, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1363 · Cited by 471
Ivermectin: 25 years and still going strong
Õmura, S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.023 · Cited by 338
A clinical drug library screen identifies astemizole as an antimalarial agent
Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio806 · Cited by 289
Mease, P. J., Russell, I. J., Arnold, L. M., Florian, H., Young, J. P., Martin, S. A., & Sharma, U. (2008) · PubMed · Cited by 268
Fluorescence Spectroscopic Profiling of Compound Libraries
Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., Shinn, P., Smith, J., Austin, C. P., Auld, D. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701301m · Cited by 262
Self-citationMiller, S. C., Huang, R., Sakamuru, S., Shukla, S. J., Attene-Ramos, M. S., Shinn, P., Van Leer, D., Leister, W., Austin, C. P., & Xia, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.021 · Cited by 250
Self-citationToxicity Testing in the 21st Century: Implications for Human Health Risk Assessment
Kavlock, R. J., Austin, C. P., & Tice, R. R. (2009) · Risk Analysis · doi:10.1111/j.1539-6924.2008.01168.x · Cited by 238
Self-citationLacro, R. V., Dietz, H. C., Wruck, L. M., Bradley, T. J., Colan, S. D., Devereux, R. B., Klein, G. L., Li, J. S., Minich, L. L., Paridon, S. M., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.024 · Cited by 231
Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases
Reeves, P. M., Bommarius, B., Lebeis, S., McNulty, S., Christensen, J., Swimm, A., Chahroudi, A., Chavan, R., Feinberg, M. B., Veach, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1265 · Cited by 226
Characterization of Chemical Libraries for Luciferase Inhibitory Activity
Auld, D. S., Southall, N. T., Jadhav, A., Johnson, R. L., Diller, D. J., Simeonov, A., Austin, C. P., & Inglese, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701302v · Cited by 183
Self-citationSafety of Drug Therapies Used for Weight Loss and Treatment of Obesity
Ioannides‐Demos, L. L., Proietto, J., Tonkin, A. M., & McNeil, J. J. (2006) · Drug Safety · doi:10.2165/00002018-200629040-00001 · Cited by 166
Pregabalin: An antiepileptic agent useful for neuropathic pain
Blommel, M. L., & Blommel, A. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060371 · Cited by 101
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Shukla, S. J., Sakamuru, S., Huang, R., Moeller, T. A., Shinn, P., VanLeer, D., Auld, D. S., Austin, C. P., & Xia, M. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035105 · Cited by 95
Self-citationDrug withdrawals from the Canadian market for safety reasons, 1963-2004
Lexchin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045021 · Cited by 78
Austin, C. P. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104426 · Cited by 57
Self-citationThalidomide: a remarkable comeback
Jacobson, J. M. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.4.849 · Cited by 46
Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS
MacArthur, R., Leister, W., Veith, H., Shinn, P., Southall, N. T., Austin, C. P., Inglese, J., & Auld, D. S. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109336954 · Cited by 23
Self-citationThe Value of USP Public Standards for Therapeutic Products
Bhattacharyya, L., Cecil, T. L., Dabbah, R., Roll, D. B., Schuber, S., Sheinin, E. B., & Williams, R. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045222.01170.4c · Cited by 21
Is pregabalin a safe and effective treatment for patients with fibromyalgia?
Spaeth, M. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0906 · Cited by 11
Cited by
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P., Hirschman, J. E., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,015
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
Self-citationImproving the Human Hazard Characterization of Chemicals: A Tox21 Update
Tice, R. R., Austin, C. P., Kavlock, R. J., & Bucher, J. R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205784 · Cited by 618
Self-citation
Metadata
- Authors
- Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P.
- Venue
- Science Translational Medicine
- Published
- 2011-04-27
- Volume
- 3
- Issue
- 80
- Pages
- 80ps16-80ps16
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2108492672
- Cited by
- 401
- References
- 29
- FWCI
- 34.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.